Quertermous Thomas 4
4 · BioCardia, Inc. · Filed Aug 23, 2019
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
Quertermous Thomas
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-07-26−3,594→ 0 totalExercise: $0.00→ Common Stock (3,594 underlying) - Exercise/Conversion
Common Stock
2019-07-26+3,594→ 15,681 total
Footnotes (4)
- [F1]Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.
- [F2]The converted RSU corresponds to a 1:1 common stock issuance.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.